ASPN and breast cancer: Notably, CAF‐derived asporin inhibits TGF‐β signaling and EMT in breast cancer cells, and overexpression of asporin in patient‐derived normal mammary fibroblasts cotransplanted with MDA‐MB‐468 xenograft reduced tumor growth and metastasis.105